Carmit Nadri-Shay
Algemeen Adviseur bij ADVAXIS, INC.
Actieve functies van Carmit Nadri-Shay
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ADVAXIS, INC. | Algemeen Adviseur | - | - |
| AYALA PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-01-2018 | - |
Loopbaan van Carmit Nadri-Shay
Eerdere bekende functies van Carmit Nadri-Shay
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Protalix Biotherapeutics Ltd.
 Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Algemeen Adviseur | - | - |
| KAMADA LTD. | Algemeen Adviseur | - | - |
Opleiding van Carmit Nadri-Shay
| Ben-Gurion University of the Negev | Doctorate Degree |
Statistieken
Internationaal
| Israël | 5 |
| Verenigde Staten | 2 |
Operationeel
| General Counsel | 4 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KAMADA LTD. | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Protalix Biotherapeutics Ltd.
Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Beurs
- Insiders
- Carmit Nadri-Shay
- Ervaring
